Pasireotide long-acting formulation (Camurus)

N/A

Report date: 2025/10/27 13:35:01

Base Information

Drug NamePasireotide long-acting formulation (Camurus)
Drug Alias NameLong-acting pasireotide depot (Camurus)CAM-4071
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionVascular endothelial growth factor A inhibitorsInsulin-like growth factor I inhibitorsCorticotropin-releasing hormone inhibitors +[4] 
TargetsInsulin-like growth factor IVascular endothelial growth factor ACorticotropin-releasing hormone +[4] 
Therapy Area/IndicationsEndocrine System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCamurus Ab
China Registration ClassN/A

Develop Information

Active CompaniesCamurus AbRhythm Pharmaceuticals Inc
Inactive CompaniesNovartis Pharma Ag
Active IndicationsEndocrine System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A